The Effect of Defining Chronic Obstructive Pulmonary Disease by the Lower Limit of Normal of FEV1/FVC Ratio in Tiotropium Safety and Performance in Respimat Participants-Reference-Cited by-同舟云学术

The Effect of Defining Chronic Obstructive Pulmonary Disease by the Lower Limit of Normal of FEV1/FVC Ratio in Tiotropium Safety and Performance in Respimat Participants

Published:2018-02 Issue:2 Volume:15 Page:200-208
ISSN:2329-6933
Container-title:Annals of the American Thoracic Society
language:en
Short-container-title:Annals ATS

Author:

Calverley Peter M. A.¹,Mueller Achim²,Fowler Andrew³,Metzdorf Norbert⁴,Wise Robert A.⁵

Affiliation:

1. Clinical Science Centre, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, United Kingdom

2. Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany

3. Boehringer Ingelheim Pharma Ltd, Bracknell, United Kingdom

4. Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany; and

5. Johns Hopkins University School of Medicine, Baltimore, Maryland

Publisher

American Thoracic Society

Subject

Pulmonary and Respiratory Medicine

Link

http://www.atsjournals.org/doi/pdf/10.1513/AnnalsATS.201703-194OC

Reference27 articles.

1. Asthma Worsenings: Approaches to Prevention and Management from the Asthma Worsenings Working Group

2. Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society

3. Underestimation of airflow obstruction among young adults using FEV1/FVC <70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes

4. Implications of adopting the Global Lungs Initiative 2012 all-age reference equations for spirometry

5. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Defining COPD in the 21st century;COPD in the 21st Century;2024-03-01

2. Longitudinal Changes and Association of Respiratory Symptoms with Preserved Ratio Impaired Spirometry (PRISm): The Nagahama Study;Annals of the American Thoracic Society;2023-11

3. Development of airflow limitation, dyspnoea, and both in the general population: the Nagahama study;Scientific Reports;2022-11-21

4. ACO (Asthma–COPD Overlap) Is Independent from COPD: The Case Against;Diagnostics;2021-06-30

5. Spirometric indices of early airflow impairment in individuals at risk of developing COPD: Spirometry beyond FEV1/FVC;Respiratory Medicine;2021-01